Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹69.70
Market cap: ₹3,064 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 90.2×Sector 47.4×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Board Meeting Date 4 Financial Results 3 Fund Raise 2 Capital Structure Change 2 Board Meeting Outcome 2 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 17:43 IST BSE

Debt & Borrowing

Shukra Pharmaceuticals Debt & Borrowing: ₹4.17 Cr

Shukra Pharmaceuticals Ltd clarified that it does not meet the SEBI criteria to be classified as a 'Large Corporate' as of April 2026. The company reported outstanding borrowings of ₹4.17 Crore as of the fiscal year-end.

Value: ₹4.17 Cr

Read the filing ↗